COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,617 Articles (22,913 medRxiv, 8,704 bioRxiv)

Most recent first Previous |  Page 1439: Articles 14381-14390  | Next

Impact of regional heterogeneity on the severity of COVID-19
Tsuzuki, S., Asai, Y., Matsunaga, N., Ishioka, H., Akiyama, T., Ohmagari, N.
10.1101/2021.06.30.21259758 — Posted: 2021-07-05
Disinfection of SARS-CoV-2 using UVC reveals wavelength sensitivity contributes towards rapid virucidal activity
Mariita, R. M., Wilson Miller, A. C., Randive, R. V.
10.1101/2021.06.30.21259769 — Posted: 2021-07-05
Incidence of outbreak-associated COVID-19 cases by industry in Ontario, Canada, April 1, 2020- March 31, 2021
Buchan, S. A., Smith, P. M., Warren, C., Murti, M., Mustard, C., Kim, J., Menon, S., Brown, K. A., van Ingen, T., Smith, B. T.
10.1101/2021.06.30.21259770 — Posted: 2021-07-05
Will Vaccine-derived Protective Immunity Curtail COVID-19 Variants in the US?
Mancuso, M., Eikenberry, S., Gumel, A.
10.1101/2021.06.30.21259782 — Posted: 2021-07-05
Analysis of Feature Influence on Covid-19 Death Rate Per Country Using a Novel Orthogonalization Technique
Gonnet, G., Stewart, J., Lafleur, J., Keith, S., McLellan, M., Jiang-Gorsline, D., Snider, T.
10.1101/2021.07.02.21259929 — Posted: 2021-07-05
Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy.
Dorlass, E. G., Lourenco, K. L., Magalhaes, R. D. M., Sato, H., Fiorini, A., Peixoto, R., Coelho, H. P., Telezynski, B. L., Scagion, G. P., Ometto, T., Thomazelli, L. M., Oliveira, D. B. L., Fernandes, A. P., Durigon, E. L., da Fonseca, F. G., Teixeira, S. M. R.
10.1101/2021.07.02.21259802 — Posted: 2021-07-05
Risk factors for intensive care admission and death amongst children and young people admitted to hospital with COVID-19 and PIMS-TS in England during the first pandemic year
Ward, J., Harwood, R., Smith, C., Kenny, S. E., Clark, M., Davis, P. J., Draper, E. S., Hargreaves, D., Ladhani, S. N., Linney, M., Luyt, K., Whittaker, E., Fraser, L. K., Viner, R. M.
10.1101/2021.07.01.21259785 — Posted: 2021-07-05 Discussion: Onsite
Risk factors for SARS-CoV-2 infection and hospitalisation in children and adolescents in Norway: A nationwide population-based study.
Stordal, K., Ruiz, P. L.-D., Greve-Isdahl, M., Suren, P., Knudsen, P. K., Gulseth, H. L., Tapia, G.
10.1101/2021.07.01.21259887 — Posted: 2021-07-05
Soft drinks can be misused to give false false positive SARS-CoV-2 lateral flow device results
Oni, L., Hawcutt, D., Buchan, I., Semple, M. G.
10.1101/2021.07.05.21260003 — Posted: 2021-07-05 Discussion: Offsite
Post-vaccination SARS-COV-2 among healthcare workers in New Jersey: a genomic epidemiological study
Mathema, B., Chen, L., Chow, K. F., Zhao, Y., Zody, M. C., Mediavilla, J. R., Cunningham, M. H., Composto, K., Lee, A., Oschwald, D. M., Germer, S., Fennessey, S., Patel, K., Wilson, D., Cassell, A., Pascual, L., Ip, A., Corvelo, A., Dar, S., Kramer, Y., Maniatis, T., Perlin, D. S., Kreiswirth, B. N.
10.1101/2021.06.30.21259761 — Posted: 2021-07-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).